4//SEC Filing
Taylor Daphne 4
Accession 0000950170-24-094813
CIK 0001671584other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:30 PM ET
Size
6.8 KB
Accession
0000950170-24-094813
Insider Transaction Report
Form 4
Taylor Daphne L
SVP, CFO
Transactions
- Exercise/Conversion
Common Stock
2024-08-08+158→ 576 total - Exercise/Conversion
Restricted Stock Unit
2024-08-08−158→ 0 total→ Common Stock (158 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001393549
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:30 PM ET
- Size
- 6.8 KB